Similar results were shown in the case of the MX-1 and MX-1/T tumor xenograft models, in which the tumors grew more aggressively due to the triple-negative breast cancer phenotypes, and S-72 still effectively inhibited both the paclitaxel-sensitive and paclitaxel-resistant breast cancer cells in vivo. This evidence concerns the gene MX1 and neoplasm.